NEW YORK (GenomeWeb News) – Helicos BioSciences reported after the close of the market Tuesday that its second-quarter revenues fell around 29 percent, as its grant and service revenues declined year over year.

The Cambridge, Mass.-based single molecule sequencing technologies firm had total revenues of $577,000 for the three months ended June 30, compared to $809,000 for the second quarter of 2011. Its service revenue fell to $175,000 from $273,000, and its grant revenue dropped to $243,000 from $427,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.